BriaCell Therapeutics Corp (BCTX, BCTXL, BCTXZ)

CIK 1610820 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BriaCell Therapeutics Corp.

Recent SEC filings

FiledFormAccession number
Oct 28, 202610-K0001493152-26-049041
Jun 26, 20268-K0001493152-26-030286
Jun 9, 202610-Q0001493152-26-027928
Jun 3, 20268-K0001493152-26-026953
Jun 2, 2026424B50001493152-26-026759
Mar 31, 20268-K0001493152-26-014156
Mar 10, 202610-Q0001493152-26-009557
Mar 9, 20268-K0001493152-26-009382
Feb 26, 202625-NSE0001354457-26-000220
Feb 20, 20268-K0001493152-26-007587
Feb 12, 2026DEF 14A0001493152-26-006390
Jan 23, 2026SCHEDULE 13G0001104659-26-006332
Jan 15, 20268-K0001493152-26-002430
Jan 14, 2026424B40001493152-26-002258
Jan 13, 2026EFFECT9999999995-26-000157
Jan 13, 2026CERT0001354457-26-000037
Jan 13, 2026S-1MEF0001493152-26-002103
Jan 13, 20268-A12B0001493152-26-001969
Dec 29, 20258-K0001493152-25-029363
Dec 23, 2025FWP0001493152-25-028923
Dec 23, 2025S-10001493152-25-028916
Dec 11, 202510-Q0001493152-25-027240
Dec 1, 20258-K0001493152-25-025469
Nov 7, 2025SCHEDULE 13G/A0001649553-25-000191
Oct 16, 202510-K0001493152-25-018212